HR Execs on the Move

Intersect ENT

www.intersectent.com

 
Intersect ENT (Nasdaq:XENT) is a medical technology company dedicated to advancing the treatment of ear, nose and throat (ENT) conditions through evidence-based innovation, providing physicians with solutions to overcome clinical challenges and improve the quality of life for patients.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Rahul Bitla
Director, Research and Development (R&D) Profile
Mark Alley
Vice President of Sales Profile
Reyna Fernandez
Chief Human Resource Officer Profile
Reyna Fernandez
Chief Human Resources Officer Profile
Gwen Carscadden
Chief People Officer Profile

Similar Companies

Doty Scientific

Doty Scientific, Inc. is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Joshi Medical Svc

Joshi Medical Svc is a North Billerica, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EG GILERO

EG GILERO is the merger of trusted companies in the medical device industry whose roots go back decades. GILERO Biomedical, Medacys, InField Medical and the medical businesses of eNNOVEA and ValTech Holdings have been brought together by EGI, Inc. to create one vertically integrated resource for the medical device industry.    EG GILERO is your single-source, trusted partner for design, development and manufacturing within the medical devices, drug delivery, and primary pharmaceutical packaging markets. With operations in the United States and Asia, EG GILERO is strategically positioned to provide the value added services our clients require in a competitive, ever-changing global marketplace.    Together, we will accelerate your device timelines from concept to commercialization.

Venus Laboratories Inc

Venus Laboratories Inc is a Wood Dale, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Becton Dickinson

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery` diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology` services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65`000 employees have a passion and commitment to help improve patient outcomes` improve the safety and efficiency of clinicians` care delivery process` enable laboratory scientists to better diagnose disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers` BD can help enhance outcomes` lower costs` increase efficiencies` improve safety and expand access to health care. In 2017` BD welcomed C. R. Bard and its products into the BD family.